Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China · Delayed Price · Currency is CNY 6.23
-0.05 (-0.80%)
May 20, 2026, 1:25 PM CST
Beijing SL Pharmaceutical Revenue
Beijing SL Pharmaceutical had revenue of 136.84M CNY in the quarter ending March 31, 2026, a decrease of -18.98%. This brings the company's revenue in the last twelve months to 591.59M, up 1.26% year-over-year. In the year 2025, Beijing SL Pharmaceutical had annual revenue of 623.64M, down -5.57%.
Revenue (ttm)
591.59M
Revenue Growth
+1.26%
P/S Ratio
10.91
Revenue / Employee
656.59K
Employees
901
Market Cap
6.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 623.64M | -36.78M | -5.57% |
| Dec 31, 2024 | 660.42M | -357.94M | -35.15% |
| Dec 31, 2023 | 1.02B | -31.81M | -3.03% |
| Jan 1, 2023 | 1.05B | -164.65M | -13.55% |
| Jan 1, 2022 | 1.21B | 102.08M | 9.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition